Letter: severe COVID‐19 infection and biologic therapies—a cohort study of 7 808 patients in France | Zendy

Bataille Pauline | Zendy; Amiot Aurélien | Zendy; Claudepierre Pascal | Zendy; Paris Nicolas | Zendy; Neuraz Antoine | Zendy; Lerner Ivan | Zendy; Garcelon Nicolas | Zendy; Rance Bastien | Zendy; Grisel Olivier | Zendy; Moreau Thomas | Zendy; Bernaux Melodie | Zendy; Audureau Etienne | Zendy; Sbidian Emilie | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Letter: severe COVID‐19 infection and biologic therapies—a cohort study of 7 808 patients in France

Author(s) -

Bataille Pauline,

Amiot Aurélien,

Claudepierre Pascal,

Paris Nicolas,

Neuraz Antoine,

Lerner Ivan,

Garcelon Nicolas,

Rance Bastien,

Grisel Olivier,

Moreau Thomas,

Bernaux Melodie,

Audureau Etienne,

Sbidian Emilie

Publication year - 2020

Publication title -

alimentary pharmacology and therapeutics

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.308

H-Index - 177

eISSN - 1365-2036

pISSN - 0269-2813

DOI - 10.1111/apt.16040

Subject(s) - medicine , covid-19 , cohort , betacoronavirus , cohort study , coronavirus infections , medline , virology , immunology , intensive care medicine , outbreak , disease , infectious disease (medical specialty) , political science , law

LINKED CONTENT This article is linked to Taxonera et al and Taxonera & Alba papers. To view these articles, visit https://doi.org/10.1111/apt.15804 and https://doi.org/10.1111/apt.16055

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research